Event Description
Please note: This event is online only.
(Please contact organizer for Zoom link and ID)
Topic
Screening for Substance Use Disorders in the Throes of the Opioid and COVID‐19 Epidemics
Presented By
Barbara Schindler, MD, Vice Dean Emerita; Professor of Psychiatry and Pediatrics
Learning Objectives
- Discuss the scope of the current opioid epidemic and its impact on health and healthcare
- Describe the impact of COVID‐19 on patients with substance use disorders
- Discuss the role of healthcare providers in the prevention, diagnosis and management of SUD’s/OUD’s during the COVID‐19 epidemic and beyond
- Explain the chronic disease model of SUD’s
- Identify patients who are high for substance use disorders and how to screen
- Describe both acute and chronic management of opioid use disorders during COVID‐19
Accredidation Statement
Tower Health is accredited by the Pennsylvania Medical Society to provide continuing medical education for physicans.
Accredidation Statement
Drexel University College of Medicine designates this live activity for a maximum of 1 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity.
Disclosure
The course director and members of the planning committee do not have any relevant financial relationships with any commercial interests to disclose regarding today's presentation.
Faculty and all others who have ability to control the content of continuing medical education activities sponsored by Tower Health are expected to disclose to the audience whether they do or do not have any real or apparent conflict(s) of interest or other relationships related to the content of their presentation(s). The ACCME defines a commercial interest as any entity producing, marketing, re-selling, or distributing health care goods or services consumed by, or used on, patients.
Barbara Schindler, MD has no relevant financial relationships to report in the last 12 months with a commercial interest. |
